Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 36 Colorectal Neoplasms 17 Small Cell Lung Carcinoma 8 Neoplasms 8 Stomach Neoplasms 7 Neoplasm Metastasis 5 Sarcoma, Ewing 4 Rhabdomyosarcoma 4 Recurrence 4 Osteosarcoma 4 Biliary Tract Neoplasms 4 Rectal Neoplasms 3 Ovarian Neoplasms 3 Cholangiocarcinoma 3 Triple Negative Breast Neoplasms 2 Solid Tumor 2 Neuroblastoma 2 Nasopharyngeal Carcinoma 2 Metastatic Pancreatic Adenocarcinoma 2 Head and Neck Neoplasms 2 Glioma 2 Glioblastoma 2 Gastrointestinal Neoplasms 2 Fallopian Tube Neoplasms 2 Esophageal Neoplasms 2 Wilms Tumor 1 Weight Loss 1 Somatostatinoma 1 Solid Tumor Cancer 1 Small Cell Lung Cancer Extensive Stage 1

Interventions

Gemcitabine 13 Albumin-Bound Paclitaxel 8 Taxes 6 130-nm albumin-bound paclitaxel 6 Fluorouracil 5 Oxaliplatin 4 dehydroftorafur 3 Radiotherapy, Intensity-Modulated 3 Radiotherapy 3 Leucovorin 3 Irinotecan 3 Losartan 2 Cisplatin 2 tocilizumab 1 selicrelumab 1 niraparib 1 irinotecan sucrosofate 1 indusatumab 1 folfirinox 1 durvalumab 1 cobimetinib 1 atezolizumab 1 X-Rays 1 Tiragolumab 1 Surgical Procedures, Operative 1 Standard of Care 1 Specimen Handling 1 S 1 (combination) 1 Resistance Training 1 Radiotherapy, Image-Guided 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Pancreatic Adenocarcinoma × irinotecan sucrosofate × Clear all

NCT03528785 2021-08-02

nITRo

Centro Ricerche Cliniche di Verona

Phase 2 Unknown

Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡